Hodgkin-limfóma: vizsgálatok itt: Csehország
7 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 12.. Ask the study team whether a trial fits you.
- 1/2. fázisTaking peopleA Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Anti-Tumor Activity of Glofitamab in Monotherapy and in Combination with Chemoimmunotherapy in Pediatric and Young Adult Participants with Relapsed/Refractory Mature B-Cell Non-Hodgkin Lymphoma
- Where
- Prague
- Életkor
- Up to 17 év
- People
- 37 worldwide
- Run by
- F. Hoffmann-La Roche AG
See details and how to join2023-504264-41-00 · EU 2023-504264-41-00 - No phaseTaking peopleEarly Detection and Screening of Hematological Malignancies - SANGUINE
- Where
- Olomouc
- Életkor
- 18 év and over
- People
- 3000 worldwide
- Run by
- JaxBio Ltd
See details and how to joinNCT05735704 - 3. fázisTaking peopleA Clinical Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Gamunex in Participants With Secondary Antibody Deficiency Associated With Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin Lymphoma
- Where
- Ostrava, Plzen 23, Praha 10
- Életkor
- 18 év and over
- People
- 49 worldwide
- Run by
- Grifols Biologicals, LLC
See details and how to joinNCT07582432 · EU 2026-526803-31-00 - 1. fázisTaking peopleA Phase 1b Open-Label Study to Evaluate the Safety and Anti-cancer Activity of Loncastuximab Tesirine in Combination with Other Anti-cancer Agents in Patients with Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (LOTIS-7)
- Where
- Ostrava, Prague, Prague 10
- Életkor
- 18 év and over
- People
- 121 worldwide
- Run by
- ADC Therapeutics SA
See details and how to joinNCT04970901 · EU 2024-512089-32-00 - 3. fázisTaking peopleA trial to learn how effective and safe odronextamab is compared to standard of care for adult participants with previously treated aggressive B-cell Non-Hodgkin Lymphoma.
- Where
- Prague 10
- Életkor
- 18 év and over
- People
- 132 worldwide
- Run by
- Regeneron Pharmaceuticals Inc.
See details and how to joinNCT06230224 · EU 2022-502783-21-00 - 1. fázisTaking peopleCART19 Cells Effects in Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia and Non-Hodgkin's Lymphoma
- Where
- Prague
- Életkor
- 18 év to 80 év
- People
- 10
- Run by
- Institute of Hematology and Blood Transfusion, Czech Republic
See details and how to joinNCT05054257 · EU 2024-510815-30-00 - No phaseTaking peoplePrognostic Significance of ctDNA in HL
- Where
- Hradec Králové, Olomouc, Prague
- Életkor
- 18 év and over
- People
- 500
- Run by
- Interni hematologicka klinika FNKV
See details and how to joinNCT06263530